Stock search

Ticker or company name

BMY card

BMY price forecast

Bristol Myers Squibb$62,93

P/E now is 14,0. Average over 5 years: 18,6 (range 15–23). The stock is 25% below its history.

Base · FY2030

$47,25−3,5% a year

The base case gives −3,5% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$49,4 bn$50,7 bn$52,0 bn$53,3 bn$54,6 bn
Net income$4,22 bn$4,33 bn$4,44 bn$4,55 bn$4,67 bn
EPS$2,11$2,21$2,31$2,42$2,54

Changed values are highlighted. Bear and bull cases: growth ∓ 5,2%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $62,93

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$23,04

Price change
−63,4%
A year
−18,2%
Fair value today
$18,59
Margin of safety
−70,5%

Base$47,25

Price change
−24,9%
A year
−3,5%
Fair value today
$36,64
Margin of safety
−41,8%

Bull$90,15

Price change
+43,3%
A year
+12,0%
Fair value today
$67,83
Margin of safety
+7,8%

What growth the price implies

For the stock to return 10% a year, revenue must grow 17,5% a year to FY2030 at a 8,5% margin and P/E 18,6.

Growth over 5 years
2,5%
Analyst consensus
no data
In your model
2,5%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$47,25−3,5% a year